Skip to main content
OpenTrials

Clinical trial condition

Infant, Newborn, Diseases

Explore clinical trials studying Infant, Newborn, Diseases. Study availability and eligibility vary by location and protocol.

2,532 public trials 320 recruiting studies
Refine in advanced search Browse all conditions

Infant, Newborn, Diseases trial results

Active, Not Recruiting

Microbial Biomarkers of EArly Pseudomonas Aeruginosa Colonization in CHildren With Cystic Fibrosis

NCT03947957

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystic Fibrosis, Digestive System Diseases, +5 more
Locations
  • CHRU Angers Angers, France
  • Hôpital des Enfants Bordeaux Bordeaux, France
  • CHU Grenoble Grenoble, France
  • Hôpital Femme-Mère-Enfant Lyon Lyon, France
View Trial Details
Active, Not Recruiting

Evaluation of Long-term Safety and Efficacy of ELX/TEZ/IVA in Cystic Fibrosis Participants 12 Months of Age and Older

NCT06460506

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystic Fibrosis, Digestive System Diseases, +5 more
Locations
  • The Kids Research Institute Australia Nedlands, Australia
  • The Royal Children's Hospital Parkville, Australia
  • Queensland Children's Hospital South Brisbane, Australia
  • The Hospital for Sick Children Toronto, Canada
View all 18 locations
View Trial Details
Active, Not Recruiting

Neurostimulation to Improve NOWS Outcomes

NCT05129020

Conditions
Chemically-Induced Disorders, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Infant, Newborn, Diseases, +5 more
Locations
  • Medical University of South Carolina - Shawn Jenkins Children's Hospital Charleston, South Carolina, United States
  • UT Southwestern Medical Center / Parkland Memorial Hospital Dallas, Texas, United States
  • University of Texas Health Science Center San Antonio San Antonio, Texas, United States
View Trial Details
Active, Not Recruiting

Evaluation of VX-121/Tezacaftor/Deutivacaftor in Cystic Fibrosis (CF) Participants 1 Through 11 Years of Age

NCT05422222

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystic Fibrosis, Digestive System Diseases, +5 more
Locations
  • Children's Hospital of Orange County Orange, California, United States
  • Stanford University Clinical and Translational Research Unit Palo Alto, California, United States
  • Children's Hospital of Colorado Aurora, Colorado, United States
  • The Emory Clinic / Children's Healthcare of Atlanta at Egleston Atlanta, Georgia, United States
View all 38 locations
View Trial Details
Active, Not Recruiting

Evaluation of VX-828 in Healthy Participants and in Participants With Cystic Fibrosis

NCT06154447

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystic Fibrosis, Digestive System Diseases, +5 more
Locations
  • Joe DiMaggio Cycstic Fibrosis & Pulmonary Center Hollywood, Florida, United States
  • AdventHealth Medical Group Pulmonology at Orlando Ridgewood Orlando, Florida, United States
  • Altasciences Clinical Kansas Overland Park, Kansas, United States
  • Kentucky Children's Hospital Lexington, Kentucky, United States
View Trial Details
Active, Not Recruiting

A Phase 1/2 Study of VX-522 in Participants With Cystic Fibrosis (CF)

NCT05668741

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystic Fibrosis, Digestive System Diseases, +5 more
Locations
  • University of Alabama at Birmingham - Child Health Research Unit Birmingham, Alabama, United States
  • Memorial Health Services on behalf of Long Beach Memorial Medical Center d/b/a Miller Children's Hospital Long Beach Long Beach, California, United States
  • Stanford University - Palo Alto - Pulmonology Palo Alto, California, United States
  • National Jewish Health Denver, Colorado, United States
View all 26 locations
View Trial Details
Active, Not Recruiting

CF Bronchodilation

NCT03522831

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystic Fibrosis, Digestive System Diseases, +10 more
Locations
  • UBC Cardiopulmonary Exercise Physiology Laboratory Vancouver, British Columbia, Canada
View Trial Details
Active, Not Recruiting

HM15136 (Efpegerglucagon) Treatment for 8 Weeks in Subjects Aged ≥2 Years With Congenital Hyperinsulinism (CHI)

NCT04732416

Conditions
Congenital Hyperinsulinism, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, +7 more
Locations
  • The Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States
  • Otto-von-Guericke-Universitaet Magdeburg Magdeburg, Germany
  • Hadassah Medical Center (HMC) Jerusalem, Israel
  • Pusan National University Yangsan Hospital Pusan, South Korea
View Trial Details

Related conditions